Co-Authors
This is a "connection" page, showing publications co-authored by Chih-Cheng Lai and Po-Ren Hsueh.
Connection Strength
19.333
-
Clinical efficacy and safety of remdesivir in patients with COVID-19: a systematic review and network meta-analysis of randomized controlled trials. J Antimicrob Chemother. 2021 07 15; 76(8):1962-1968.
Score: 0.956
-
COVID-19 vaccines and thrombosis with thrombocytopenia syndrome. Expert Rev Vaccines. 2021 08; 20(8):1027-1035.
Score: 0.955
-
COVID-19 vaccines: concerns beyond protective efficacy and safety. Expert Rev Vaccines. 2021 08; 20(8):1013-1025.
Score: 0.955
-
Clinical efficacy of antiviral agents against coronavirus disease 2019: A systematic review of randomized controlled trials. J Microbiol Immunol Infect. 2021 Oct; 54(5):767-775.
Score: 0.953
-
Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021 Apr; 57(4):106324.
Score: 0.935
-
The impact of the coronavirus disease 2019 epidemic on notifiable infectious diseases in Taiwan: A database analysis. Travel Med Infect Dis. 2021 Mar-Apr; 40:101997.
Score: 0.931
-
The impact of COVID-19 preventative measures on airborne/droplet-transmitted infectious diseases in Taiwan. J Infect. 2021 03; 82(3):e30-e31.
Score: 0.915
-
How to Keep COVID-19 at Bay: A Taiwanese Perspective. J Epidemiol Glob Health. 2021 03; 11(1):1-5.
Score: 0.912
-
Population-based seroprevalence surveys of anti-SARS-CoV-2 antibody: An up-to-date review. Int J Infect Dis. 2020 Dec; 101:314-322.
Score: 0.907
-
In vitro diagnostics of coronavirus disease 2019: Technologies and application. J Microbiol Immunol Infect. 2021 Apr; 54(2):164-174.
Score: 0.886
-
Co-infections among patients with COVID-19: The need for combination therapy with non-anti-SARS-CoV-2 agents? J Microbiol Immunol Infect. 2020 Aug; 53(4):505-512.
Score: 0.883
-
Extra-respiratory manifestations of COVID-19. Int J Antimicrob Agents. 2020 Aug; 56(2):106024.
Score: 0.883
-
Global coronavirus disease 2019: What has daily cumulative index taught us? Int J Antimicrob Agents. 2020 Jun; 55(6):106001.
Score: 0.879
-
Global epidemiology of coronavirus disease 2019 (COVID-19): disease incidence, daily cumulative index, mortality, and their association with country healthcare resources and economic status. Int J Antimicrob Agents. 2020 Apr; 55(4):105946.
Score: 0.873
-
Asymptomatic carrier state, acute respiratory disease, and pneumonia due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): Facts and myths. J Microbiol Immunol Infect. 2020 Jun; 53(3):404-412.
Score: 0.870
-
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020 Mar; 55(3):105924.
Score: 0.867
-
Susceptibility rates of clinically important bacteria collected from intensive care units against colistin, carbapenems, and other comparative agents: results from Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART). Infect Drug Resist. 2019; 12:627-640.
Score: 0.813
-
Methicillin-resistant Staphylococcus aureus sequence type 45 with high rates of ciprofloxacin and tetracycline resistance in the residents and environments of long-term care facilities in Taiwan. J Infect. 2018 03; 76(3):305-307.
Score: 0.743
-
Time to positivity in blood cultures of staphylococci: clinical significance in bacteremia. J Infect. 2011 Mar; 62(3):249-51.
Score: 0.463
-
Current challenges in the management of invasive fungal infections. J Infect Chemother. 2008 Apr; 14(2):77-85.
Score: 0.383
-
Empyema thoracis due to Rhizopus oryzae in an allogenic bone marrow transplant recipient. Med Mycol. 2006 Feb; 44(1):75-8.
Score: 0.328
-
Tocilizumab for severe COVID-19: a systematic review and meta-analysis. Int J Antimicrob Agents. 2020 Sep; 56(3):106103.
Score: 0.223
-
COVID-19 in long-term care facilities: An upcoming threat that cannot be ignored. J Microbiol Immunol Infect. 2020 Jun; 53(3):444-446.
Score: 0.219
-
Emergence of multidrug-resistant Candida auris in Taiwan. Int J Antimicrob Agents. 2019 May; 53(5):705-706.
Score: 0.203
-
Implementation of a national quality improvement program to enhance hand hygiene in nursing homes in Taiwan. J Microbiol Immunol Infect. 2019 Apr; 52(2):345-351.
Score: 0.197
-
Clinical characteristics of patients with bacteraemia due to the emergence of mcr-1-harbouring Enterobacteriaceae in humans and pigs in Taiwan. Int J Antimicrob Agents. 2018 Nov; 52(5):651-657.
Score: 0.196
-
Implementation of a national bundle care program to reduce central line-associated bloodstream infections in intensive care units in Taiwan. J Microbiol Immunol Infect. 2018 Oct; 51(5):666-671.
Score: 0.185
-
Clinical manifestations of candidemia caused by uncommon Candida species and antifungal susceptibility of the isolates in a regional hospital in Taiwan, 2007-2014. J Microbiol Immunol Infect. 2019 Aug; 52(4):612-619.
Score: 0.183
-
Implementation of a national bundle care program to reduce catheter-associated urinary tract infection in high-risk units of hospitals in Taiwan. J Microbiol Immunol Infect. 2017 Aug; 50(4):464-470.
Score: 0.181
-
Presence of multidrug-resistant organisms in the residents and environments of long-term care facilities in Taiwan. J Microbiol Immunol Infect. 2017 Apr; 50(2):133-144.
Score: 0.176
-
Clinical characteristics of infections caused by Roseomonas species and antimicrobial susceptibilities of the isolates. Diagn Microbiol Infect Dis. 2012 Mar; 72(3):199-203.
Score: 0.123
-
Fatal Citrobacter farmeri meningitis in a patient with nasopharyngeal cancer. J Clin Microbiol. 2010 Apr; 48(4):1499-500.
Score: 0.109
-
Predominance of methicillin-resistant Staphylococcus aureus in the residents and environments of long-term care facilities in Taiwan. J Microbiol Immunol Infect. 2019 Feb; 52(1):62-74.
Score: 0.047